Výsledky vyhledávání - "Piet P M M, Geusens"

Akademický článek

Prevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht Study

Autor: Veerle van Hulten, Cindy Sarodnik, Johanna H. M. Driessen, Nicolaas C. Schaper, Piet P. M. M. Geusens, Carol A. B. Webers, Geert-Jan Dinant, Ramon P. G. Ottenheijm, Nicklas H. Rasmussen, Rikke Viggers, Coen D. A. Stehouwer, Carla J. H. van der Kallen, Miranda T. Schram, Sandrine P. G. Bours, Pieter C. Dagnelie, Joop P. van den Bergh

Publikováno v: Frontiers in Endocrinology, Vol 13 (2022)

BackgroundType 2 diabetes (T2D) is frequently reported to be associated with an increased fracture risk. Epidemiological data on prevalent morphometric vertebral fractures (VFs) in T2D are sparse and even less is known in the prediabetic state.Purpos

Externí odkaz: https://doaj.org/article/4c56f9dc04d1474bb9af9ea5836f5690

Zobrazit plný text záznamu

What Is the Diagnostic Performance of Conventional Radiographs and Clinical Reassessment Compared With HR-pQCT Scaphoid Fracture Diagnosis?

Autor: Anne M. Daniels, Josephine Kranendonk, Caroline E. Wyers, Heinrich M. J. Janzing, Sander Sassen, Bert van Rietbergen, Piet P. M. M. Geusens, Sjoerd Kaarsemaker, Pascal F. W. Hannemann, Martijn Poeze, Joop P. van den Bergh

Publikováno v: Clinical Orthopaedics and Related Research, 481(1), 97-104. Springer
Clinical Orthopaedics and Related Research, 481(1), 97-104. Springer Verlag

BACKGROUND: Conventional radiographs and clinical reassessment are considered guides in managing clinically suspected scaphoid fractures. This is a unique study as it assessed the value of conventional radiographs and clinical reassessment in a cohor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c4512a46f8bbfa03becb1bc0eac3c6
https://doi.org/10.1097/corr.0000000000002310

Zobrazit plný text záznamu

High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial

Autor: Jos N, Hoes, Johannes W G, Jacobs, Harry M J, Hulsmans, Ron N J, De Nijs, Willem F, Lems, George A W, Bruyn, Piet P M M, Geusens, Johannes W J, Bijlsma

Publikováno v: Clinical and experimental rheumatology. 28(3)

In the 18 month "alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial (STOP-trial) patients with rheumatic diseases who started glucocorticoids were randomised to anti-osteoporosis therapy with either daily alendronate (10 mg) or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::02723ec60c8ef47b9a31652b4b7331e3
https://pubmed.ncbi.nlm.nih.gov/20406615

Zobrazit plný text záznamu

Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis

Autor: Johannes W G, Jacobs, Ron N J, de Nijs, Willem F, Lems, Piet P M M, Geusens, Roland F J, Laan, Anne-Margriet, Huisman, Ale, Algra, Erik, Buskens, Lorenz C, Hofbauer, Ans C M, Oostveen, George A W, Bruyn, Ben A C, Dijkmans, Johannes W J, Bijlsma

Publikováno v: The Journal of rheumatology. 34(5)

To explore the relation of changes in measures of bone turnover and changes in bone mineral density (BMD) of the lumbar spine and total hip over 18 months in a double-blinded, randomized trial, comparing the effect of alfacalcidol (101 patients) vers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b2aa9a25b4610ea76d1346844befbe5a
https://pubmed.ncbi.nlm.nih.gov/17407214

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání